| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 5,000 | $92.76 | $463,794.12 | -0.1% | +12.2% | - | |
| Dec 1, 2025 | RMD Resmed Inc | Rider Michael J50 | Global General Counsel | Sell | 50 | $244.16 | $12,208.00 | -0.5% | +3.6% | - | |
| Dec 1, 2025 | RMD Resmed Inc | Sandercock Brett63 | Chief Financial Officer | Sell | 1,000 | $244.16 | $244,160.00 | -1.1% | +3.6% | - | |
| Nov 28, 2025 | OSUR Orasure Technologies Inc | Gagliano Nancy J63 | Director | Buy | 2,100 | $2.37 | $4,981.83 | +1.3% | +29.0% | - | |
| Nov 28, 2025 | BFLY Butterfly Network, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Sell | 132,570 | $3.08 | $408,183.03 | -20.5% | +50.6% | - | |
| Nov 28, 2025 | INSP Inspire Medical Systems, Inc. | McCormick Shawn78 | Director | Sell | 2,000 | $127.48 | $254,960.00 | -7.1% | -45.3% | - | |
| Nov 26, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul78 | Chief Data Officer | Sell | 1,986 | $3.51 | $6,970.86 | -1.2% | -31.6% | - | |
| Nov 26, 2025 | ATRC Atricure, Inc. | Noznesky Justin J67 | Chief Mktg &Strategy Officer | Sell | 5,166 | $37.29 | $192,640.14 | -6.2% | -13.6% | - | |
| Nov 26, 2025 | QDEL Quidelortho Corp | Wilkins Joseph D Jr. | Director | Buy | 370 | $27.95 | $10,343.35 | +3.2% | -20.3% | - | |
| Nov 26, 2025 | BLFS Biolife Solutions Inc | Duross Amy63 | Director | Sell | 4,000 | $27.00 | $108,000.00 | -8.4% | -15.1% | - | |
| Nov 26, 2025 | BFLY Butterfly Network, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Sell | 2,227,876 | $3.18 | $7,089,929.58 | -30.2% | -4.2% | - | |
| Nov 25, 2025 | Huller Kelly58 | SVP, GC, Corporate Secretary | Sell | 7,500 | $90.00 | $675,000.00 | -100% | +2.4% | - | ||
| Nov 25, 2025 | RGEN Repligen Corp | Loeillot Olivier | Chief Executive Officer | Sell | 7,041 | $170.00 | $1,196,970.00 | -16.4% | -21.0% | - | |
| Nov 25, 2025 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.61 | Chief Legal Officer | Sell | 44,850 | $8.08 | $362,388.00 | -14.9% | -33.8% | - | |
| Nov 25, 2025 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 1,800 | $300.06 | $540,108.00 | -2.7% | +13.6% | - | |
| Nov 25, 2025 | BLFS Biolife Solutions Inc | Werner Sean60 | Chief Technology Officer | Sell | 110 | $26.74 | $2,941.40 | -0.4% | -15.2% | - | |
| Nov 25, 2025 | GKOS Glaukos Corp | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 315 | $105.00 | $33,075.00 | -0.6% | +15.4% | - | |
| Nov 25, 2025 | QDEL Quidelortho Corp | Widder Kenneth J | Director | Sell | 4,026 | $27.81 | $111,965.48 | -9.8% | -24.7% | - | |
| Nov 25, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.67 | Chief Quality And Operations | Sell | 415 | $26.74 | $11,097.10 | -0.2% | -15.2% | - | |
| Nov 25, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 526 | $26.74 | $14,065.24 | -0.1% | -15.2% | - | |
| Nov 25, 2025 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 351 | $26.74 | $9,385.74 | -0.3% | -15.2% | - | |
| Nov 25, 2025 | ICUI Icu Medical Inc/de | Woolson Daniel56 | VP, Gm-infusion Capital | Sell | 2,897 | $152.35 | $441,364.32 | -20.4% | -0.2% | - | |
| Nov 25, 2025 | ABT Abbott Laboratories | Shroff Eric | Senior Vice President | Sell | 1,586 | $128.02 | $203,042.57 | -5.0% | -10.0% | - | |
| Nov 25, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 584 | $26.74 | $15,616.16 | -0.3% | -15.2% | - | |
| Nov 25, 2025 | ENOV Enovis Corp | Kleckner John62 | Principal Accounting Officer | Buy | 2,468 | $30.32 | $74,829.76 | +25.1% | -26.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.